This page is a selection of current research funding for antimicrobial resistance. It is not specific to any regions, technologies or approaches. We aim to keep this list up to date and as comprehensive as possible, but it is not exhaustive. If you know of AMR funding available not listed here, longitude.prize [at] nesta.org.uk (please let us know). As opportunities are very different, please check respective websites for full details.
Antimicrobial Resistance Diagnostic Challenge
Funder: U.S. National Institutes of Health (NIH), Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services, U.S.
Funds available: US$20million
Country focus: United States
Status: Submission window now closed.
Antimicrobial Resistance Competition
Funder: UK Department of Health via Innovate UK
Funds available: £4million
Country focus: United Kingdom
Next deadline: Registration window now closed.
Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
Funders/partners: Boston University, BARDA, National Institute of Allergy and Infectious Diseases, US (NIAID), AMR Centre, Wellcome Trust, California Life Sciences Institute, MAssBIO, The Broad Institute
Funds available: At least US$250million with matching funds from partners
Country focus: Worldwide
Next deadline: Expression of Interest cycles 1 and 2 windows are now closed. Details of initiation of cycle 3 not yet released; please visit website.